nab-Paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC): Interim efficacy and safety results from the Phase 2 LAPACT Trial Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Philip, P. A.; Lacy, J.; Portales, F.; Sobrero, A.; Pazo-Cid, R.; Manzano Mozo, J. L.; Kim, E. S.; Dowden, S.; Zakari, A.; Borg, C.; Terrebonne, E.; Rivera Herrero, F.; Shiansong Li, J.; Ong, T. J.; Nydam, T.; Hammel, P.

authors

Publication Date

  • September 1, 2017

webpage

published in

category

volume

  • 28